Page last updated: 2024-11-04

sulfasalazine and Lichen Sclerosis

sulfasalazine has been researched along with Lichen Sclerosis in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taveira, M1
Selores, M1
Costa, V1
Massa, A1

Other Studies

1 other study available for sulfasalazine and Lichen Sclerosis

ArticleYear
Generalized morphea and lichen sclerosus et atrophicus successfully treated with sulphasalazine.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 1999, Volume: 12, Issue:3

    Topics: Aged; Anti-Infective Agents; Female; Humans; Lichen Sclerosus et Atrophicus; Scleroderma, Localized;

1999